 | Up a level |
Journal Article
Huober, J., Janni, W., Untch, M., Blohmer, J-U., Zahm, D-M., Hanusch, C., Jackisch, C., Heinrich, G., Schneeweiss, A., Denkert, C., Link, T., Rhiem, K. E., Furlanetto, J., Solbach, C., Klare, P., Nekljudova, V., Filmann, N. and Loibl, S. (2022). Long-term survival of a randomised, open-label, phase II study comparing the efficacy and safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE). Ann. Oncol., 33 (7). S. S615 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Laakmann, E., Witzel, I., Neunhoeffer, T., Park-Simon, T-W., Weide, R., Riecke, K., Polasik, A., Schmidt, M., Puppe, J., Mundhenke, C., Luebbe, K., Hesse, T., Thill, M., Zahm, D-M., Denkert, C., Fehm, T., Nekljudova, V., Rey, J., Loibl, S. and Mueller, V. (2021). Characteristics of patients with brain metastases from HER2-positive breast cancer. Ann. Oncol., 32. S. S63 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Labidi-Galy, S. I., Schneeweiss, A., Sinn, H. P., Blohmer, J-U., Romanens, L., Zahm, D-M., Huober, J., Dohnal, D., Link, T., Hanusch, C., Jackisch, C., Fasching, P. A., Solbach, C., Rhiem, K. E., Denkert, C., Weber, K. E., Lederer, B., Untch, M., Loibl, S. and Furlanetto, J. (2021). Baseline menopausal status, Ki-67 and stromal tumour-infiltrating lymphocytes (TILs) and association with outcome in triple-negative breast cancer (TNBC): Exploratory analysis in GeparSixto. Ann. Oncol., 32. S. S49 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Riecke, K., Laakmann, E., Neunhoffer, T., Park-Simon, T-W., Weide, R., Schmidt, M., Polasik, A., Puppe, J., Mundhenke, C., Luebbe, K., Hesse, T., Thill, M., Zahm, D-M., Denkert, C., Fehm, T., Nekljudova, V., Rey, J., Loibl, S., Mueller, V. and Witzel, I. (2022). Long-term survival of breast cancer patients with brain metastases: Subanalysis of the BMBC registry. Ann. Oncol., 33. S. S202 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041